SHL Medical AG products

Inheriting the classic Molly’s compact design and simplicity of use, this second-generation Molly autoinjector is designed with a new ergonomic body and a flange-shaped anti-roll cap for an easier handling experience. Built on a modular platform technology, Molly is designed to meet the evolving requirements of future autoinjectors, such as introducing unique designs for branding and user requirements, as well as high-volume manufacturing.

The establishment of the Molly platform signifies SHL’s commitment to further addressing the varying needs of our customers and their patients. Introduced in 2010, Molly is SHL’s first preconfigured autoinjector designed to help pharmaceutical companies reduce initial investments and expedite development timelines.

2006 marked the commercial launch of one of the world’s first modern autoinjectors – SHL’s Disposable Autoinjector, more commonly known as DAI. The first DAI was built for a multinational biopharmaceutical company headquartered in the US. It is a button-activated, 3-step disposable device for 1 mL pre-filled syringes. We were tasked to design an injection device that could facilitate an easier subcutaneous self-injection experience compared to the alternative pre-filled syringe or vial. For this reason, DAI features an ergonomic interface with two audible clicks at the beginning and end of injection, as well as an automatic delivery mechanism that successfully delivers the drug in a matter of seconds. As one of the first modern autoinjectors, DAI helped set the standard for biological self-injection treatments worldwide.

The development of the Precision Pen Injector (PPI) is a story of uncompromising dedication to meeting industry challenges. A Swedish company specializing in solutions for aesthetics and corrective treatment sought to introduce an autoinjector for its skin booster – a highly viscous hyaluronic acid formulation of several hundred centipoise. The company needed a device that could deliver small and very precise doses of this treatment while addressing the challenges the filler market did not have at the time, such as drooling and overdosing.

SHL’s dedication to designing patient-centric products is evident in our very first injector, the PenInject 2.25.